Lexicon Pharmaceuticals
LXRX
#6320
Rank
โ‚น99.66 B
Marketcap
โ‚น223.99
Share price
0.86%
Change (1 day)
126.28%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -โ‚น6.29

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น6.70. In 2025 the company made an earnings per share (EPS) of -โ‚น13.40 an increase over its 2024 EPS that were of -โ‚น61.26.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น6.29-53.08%
2025-โ‚น13.40-78.13%
2024-โ‚น61.26-20%
2023-โ‚น76.5831.15%
2022-โ‚น58.39-0%
2021-โ‚น58.3910.91%
2020-โ‚น52.65-145.08%
2019โ‚น116.78-206.09%
2018-โ‚น110.08-5.74%
2017-โ‚น116.78-10.95%
2016-โ‚น131.142640%
2015-โ‚น4.79-96.34%
2014-โ‚น130.62-2.53%
2013-โ‚น134.01-9.09%
2012-โ‚น147.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,744-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น529.35-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,071-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น584.87 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น750.47-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.91-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น71.79 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น134.01-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1,56,675 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA